Marks & Clerk is proud to announce that three of our Canadian Partners and one Canadian associate have been appointed to serve as Committee Chairs for the Intellectual Property Institute of Canada (IPIC).
This article discusses the Royalty Pharma v Boehringer judgment from the UK’s Patents Court which covers a number of interesting points on German patent licensing and substantive patent law.
